These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors. Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds. Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors. Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807 [TBL] [Abstract][Full Text] [Related]
19. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269 [TBL] [Abstract][Full Text] [Related]
20. Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Lévesque JF; Bleasby K; Chefson A; Chen A; Dubé D; Ducharme Y; Fournier PA; Gagné S; Gallant M; Grimm E; Hafey M; Han Y; Houle R; Lacombe P; Laliberté S; MacDonald D; Mackay B; Papp R; Tschirret-Guth R Bioorg Med Chem Lett; 2011 Sep; 21(18):5547-51. PubMed ID: 21784634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]